The National Medical Products Administration (NMPA) has issued the “Measures for the Standard Management of Drugs”, which will be effective from January 1, 2024. The standard involved in the method is “according to the physicochemical and biological characteristics of the drug itself, in accordance with the source, prescription, production method and transportation, storage and other conditions to assess the quality of the drug within the effective period to meet the requirements of medicine, and to measure whether its quality is uniform and stable technical requirements.” Drug standards are the basic standards for evaluating the safety, effectiveness and quality of the basic attributes of drugs. They are of great significance to corporate drug research and development and ensuring public drug safety. The issuance of this management measure is conducive to strengthening drug management and promoting the healthy development of the pharmaceutical industry. Please contact us by email or phone for more details.